Anti-aging medicine is flourishing, with methods already available to slow down or even reverse aging. Diseases such as cancer and dementia may become treatable in the near future, contributing to a healthier elderly population.
The U.S. National Institute on Aging states that the field of aging research has seen explosive progress over the past 20 years, bringing us ever closer to the goal of preventing age-related diseases.
Most research in this area to date has been conducted on simple organisms like animals and worms to measure and alter life expectancy. For example, researchers have discovered that modifying 17 genes, which are also present in humans, can double the lifespan of nematodes and extend the lifespan of mice by 60%.
They also found that significantly reducing caloric intake can have the same effect on these genes. Researchers note that many diseases are caused by the accumulation of cellular damage, and the metabolic changes resulting from long-term fasting appear to stimulate the natural clearance of damaged cells in the body. However, long-term caloric restriction is difficult to maintain, and there are now drugs that can mimic the effects of reduced calorie intake.
Of the 20 molecules tested on mice so far, seven have been found to extend lifespan, including the immunosuppressant rapamycin, which can extend the lifespan of mice by 25%.
This drug is typically used for terminally ill patients and can cause many side effects; however, when tested on healthy individuals, no side effects were observed, making it seem like a miracle cure.
Another promising anti-aging method is to induce self-destruction in senescent cells that can no longer divide. Experiments show that eliminating these dysfunctional senescent cells can help mice live longer and healthier lives. 15 to 20 such drugs are currently undergoing testing.
Recent research on the Amish community further demonstrates the powerful effect of a single gene mutation in preventing aging. Dr. Vahan, a cardiologist at Northwestern University, says this is the first gene mutation discovered in humans that appears to prevent multiple aspects of physiological aging.
This mutation, which leads to a sharp reduction in the PAI-1 protein, allows people to remain robust in their old age. Amish individuals with this gene mutation have an average life expectancy of 85 years, significantly higher than the 71-year average for the general Amish population. Japan is currently conducting clinical trials on a molecule that mimics this effect.
Dr. Vahan states that the development of anti-aging drugs is advancing rapidly, and within 20 to 30 years, there will be drugs capable of slowing the aging process or preventing age-related diseases.
With the continuous improvement of economic and material standards, more and more people are beginning to focus on health and wellness. Retirement and medical care have become one of the drivers for investment immigration. Malta, located in the heart of the Mediterranean, has become a popular immigration destination for many investors due to its superior environment and advanced medical care. As a premier destination for retirement, Malta ranks first in the European Union, with its citizens spending 90% of their lives in good health. In the annual health-related index recently published by The Lancet, a renowned medical journal often described as a 'window into the medical world,' Malta's healthcare sector stood out among 195 countries, ranking 9th globally. In this assessment, Malta's performance improved by 5 places compared to last year, achieving full marks in 10 indicators, 80 points in 28 areas, and an overall average score of 79.
Through the Malta Government Bond Investment Program, you can obtain permanent residency in Malta for your entire family of four generations quickly with an investment starting from just 70,000 euros. You are paying interest to gain permanent residency in the Schengen Area for four generations of your family. After holding the investment for 5 years, there is no concern about bond depreciation or the need to sell bonds for cash, allowing your whole family to fully enjoy everything Malta has to offer.
Worldway Group kindly reminds you: By using the financing model for the Malta Government Bond Investment Program, you can also enjoy a significant discount of 430,000 RMB. This offer expires on February 15, 2019. Interested investors should act quickly to complete the application.
Investment immigration to Malta requires the selection of a professional agency. As a pioneer in European investment immigration, Worldway Group has been sparing no effort for 22 years to promote high-quality investment immigration programs in European countries. We continuously set industry precedents and maintain excellent relationships with the governments of Malta and other European countries, serving as a solid backing on your immigration journey! For more details, please call: 400-138-2929.
Disclaimer:
Some materials in this article are sourced from the internet, and the copyright belongs to the original author. If there are any issues regarding copyright, please contact us for removal.